Stents

TCT 2016, TCT.16, main arena, late breaking trials
Feature | Cath Lab | September 28, 2016

September 28, 2016 — The Cardiovascular Research Foundation (CRF) has announced the 11 late-breaking trials and 16...

News | Venous Therapies | September 12, 2016

September 12, 2016 — Veniti Inc. has closed on $25 million in Series D equity financing from Boston Scientific Corp...

Intact Vascular, TOBA clinical study, one-year results, Tack Endovascular System, Journal of Vascular Surgery
News | Peripheral Arterial Disease (PAD) | August 24, 2016

August 24, 2016 — Intact Vascular Inc. announced that the one-year results from its Tack Optimized Balloon...

Absorb, bioresorbable stent, BVS, on OCT

An optical coherence tomography (OCT) image of an Absorb bioresorbable stent. The stent struts are clear, allowing light to pass through, and in some cases magnifying the light that passes through under each strut. Image courtesy of St. Jude Medical.

Blog | Stents Bioresorbable | August 16, 2016

There was an explosion of interest in bioresorbable stents immediately following the July 5, 2016 announcement that...

Absorb, bioresorbable stent, FDA approval, FDA approves, FDA clears, most popular content, most popular stories, DAIC

The FDA clearance of the first bioresorbable stent, the Abbott Absorb, the first week of July has been the most popular story so far for all of 2016. It is the first fully dissolving stent approved for the U.S. market and many experts say this technology could be a paradigm shift in coronary and peripheral therapies in the coming years as the technology improves. 

Feature | August 05, 2016 | Dave Fornell

 

August 5, 2016 — Here are the top 20 most popular current content on the Diagnostic and Interventional...

Gore, Tigris stent, fluoropolymer nitinol stent, peripheral artery disease

The Gore Tigris is a dual-component stent with a unique fluoropolymer / nitinol design.

Technology | Stents Peripheral | August 02, 2016

August 2, 2016 —The U.S. Food and Drug Administration (FDA) granted market clearance for W. L. Gore & Associates...

Abbott, Absorb bioresorbable stent, dissolving, UAB, University of Alabama at Birmingham, first in state
News | Stents Bioresorbable | July 26, 2016

July 26, 2016 — On July 20, Massoud Leesar, M.D., of University of Alabama at Birmingham Hospital implanted a...

SJM, OCT, Optical coherence tomography, Bioresorbable stent, BVS

Both IVUS and OCT imaging can be used to visualize bioresorbable stents. This optical coherence tomography (OCT) image shows an Absorb bioresorbable stent. The stent struts are clear, allowing light to pass through, and in some cases magnifying the light that passes through under each strut. Image courtesy of St. Jude Medical.

Feature | Stents Bioresorbable | July 21, 2016 | Alphonse Ambrosia, D.O.

Some have labeled bioresorbable scaffolds (BRS), also known as bioresorbable stents, as the fourth evolution of...

Abbott Absorb bioresorbable stent, dissolving BVS, first West Coast implant, Good Samaritan Hospital Los Angeles
News | Stents Bioresorbable | July 19, 2016

July 19, 2016 — Good Samaritan Hospital, Los Angeles, is the first hospital on the West Coast to offer patients with...

Abbott, Absorb bioresorbable stent, University Hospitals Case Medical Center, first Midwest implant
News | Stents Bioresorbable | July 11, 2016

July 11, 2016 — University Hospitals Case Medical Center, Cleveland, is among the first in the country – and the...

Absorb, bioresorbable stent, FDA approval, FDA approves, FDA clears, dissolving stent

The Abbott Absorb is the first bioresorbable stent to be cleared for use in the United States. 

Technology | Stents Bioresorbable | July 05, 2016 | Dave Fornell

July 5, 2016 — The U.S. Food and Drug Administration (FDA) has cleared the first fully bioresorbable coronary stent...

Intact Vascular, TOBA III clinical study, Europe, Tack Endovascular System, peripheral artery disease, PAD
News | Peripheral Arterial Disease (PAD) | June 07, 2016

June 7, 2016 — Intact Vascular Inc. announced that its Tack Optimized Balloon Angioplasty III (TOBA III)...

News | Stents Bioresorbable | June 06, 2016

June 6, 2016 — Amaranth Medical announced that it completed enrollment in May in the RENASCENT-II study of its novel...

Biotronik, ORIENT trial results, EuroPCR 2016, Orsiro DES, hybrid drug-eluting stent
News | Stents Drug Eluting | June 03, 2016

June 3, 2016 — Biotronik announced results establishing non-inferiority of the Orsiro hybrid...

congenital heart, pulmonary artery stenting, JACC study
News | Congenital Heart | May 31, 2016

May 31, 2016 — In a recent study, the use of a ...

Overlay Init